Skip to content

Effect of black and joha rice intake on diabetic and /or hyperlipidemic patients

Evaluation of the effect of black rice and joha rice intake on hyperlipidemia, hyperglycemia and antioxidant activity in diabetic/hyperlipidemic patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/12/022265
Enrollment
135
Registered
2019-12-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: E116- Type 2 diabetes mellitus with other specified complications

Interventions

Intervention1: Black rice or Joha rice with Bran: Patient will ask to take Joha rice and black rice with bran for six months instead of regular rice. Rice will be given twice per day [Quantity of rice

Sponsors

Assam down town University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient with mild or moderate hyperlipidemia Diabetic patient with risk of hyperlipidemia HbA1C within 6.5-10.5%

Exclusion criteria

Exclusion criteria: Patient who are not hospitalized within last 6 months Patient with chronic and uncontrolled hyperlipidemia/blood sugar (HbA1C > 10.5% ) If serum creatinine level > 2 mg/dl If serum TG level > 500 mg/dl If SGOT, SGPT is 2.5 times more than normal level If ketone present in urine Patient taking statin drugs Patients have diabetic complecations like CKD, MI etc (clinical decision to be taken)

Design outcomes

Primary

MeasureTime frame
Beneficial effect in managing and controlling diabetes and hyperlipidemia Following parameters will be checked at 0 [Baseline] 3 month and 6 months. Blood sugar [FBS and PPBS] HbA1 Serum lipid profile Serum creatinineTimepoint: 0 months[Baseline] 3 months 06 months

Secondary

MeasureTime frame
We will follow up the followings Disease progression Health status Complications arises due to diabetes mellitus Cardiovascular complications Compliance of the advice and diet The information will be collected by interviewing the patients (no health check up, testing of blood or biochemical parameter will not be carry out to measure secondary outcome). In this period no active intervention will be provided from our side. Timepoint: 1 year 3 year 5 year

Countries

India

Contacts

Public ContactDr Saikat Sen

Assam down town University

saikat.pharm@rediffmail.com8638603899

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026